Pharmaceutical Technology

FEBRUARY 10, 2023

This is not the first treatment to come with a high price tag. Partly in response to such drugs, risk-sharing agreements (RSAs) have increased in popularity and aim to mitigate the risks of including high-cost drugs on reimbursement lists and healthcare plans.

Gene Therapy 263

Gene Therapy Marketing Gene Drugs 263

The Pharma Data

JANUARY 31, 2021

Clover plans to initiate a global phase 2/3 trial in the first half of 2021 with an interim analysis for vaccine efficacy potentially in the middle of 2021. Utilizing Clover’s proprietary Trimer-Tag© technology, S-Trimer is a trimeric SARS-CoV-2 spike (S)-protein subunit vaccine candidate. CHENGDU, China , Feb.

Clinical Trials 52

Clinical Trials Clinical Trials Vaccination Vaccine 52

Rethinking Clinical Trials

MAY 10, 2023

nonprofits and nonprofit/for-profit academic and healthcare organizations. All of Us will expand the data available for participants, launch ancillary studies as a core and scalable capability, establish a diverse global community of 10,000 researchers, and incorporate participant return of value into data collections and assess its impact.

Medicine 130

Medicine Research Clinical Trials Clinical Trials 130

XTalks

FEBRUARY 8, 2024

Along with the hefty price tag for screen time that may not be perceived to be a worthwhile investment, and despite favoring advertising at other major events like the Grammys, pharma tends to stay somewhat clear of all the Super Bowl hoopla.

Life Science 105

Life Science Marketing Branding Drugs 105

The Pharma Data

DECEMBER 3, 2020

Thus, the ability of Clover’s COVID-19 vaccine candidates to be stored in standard refrigeration temperatures makes them suitable for broad global distribution based on current results. A global Phase 2/3 efficacy study of the S-Trimer vaccine candidate in combination with GSK’s pandemic adjuvant system is expected to begin in December 2020.

Vaccination 52

Vaccination Vaccine Immune Response Protein 52

pharmaphorum

AUGUST 17, 2020

In this article Joanna Carlish, managing director of financial services at Tag Americas , and Robb DeFilippis, Tag Americas’ managing director, life sciences, go head-to-head to discuss marketing within a regulated industry. Joanna Carlish, managing director, financial services, Tag Americas. Virtual connections.

Regulation 77

Regulation Marketing Sales Branding 77

Drug Discovery World

JANUARY 30, 2024

I don’t think anyone disagrees that we need to bring down pricing to increase patient adoption and take strain off healthcare reimbursement systems. Reimbursement models: Current healthcare systems may not have appropriate reimbursement models for the one-time, high-cost nature of CGTs.

Gene Therapy 71

Gene Therapy Manufacturing Gene Clinical Trials 71

Pharmaceutical Technology

MARCH 22, 2023

The pharmaceutical industry began using radio frequency identification (RFID) tags in the early 2000s. Pfizer was the first to use the tech, adding RFID tags to track a Viagra (sildenafil) shipment circa 2006. Twenty years ago, the cost of implementing RFID tags and the ecosystem (software) was much more expensive than today.

Production 264

Production Pharma Production Pharma Companies Drugs 264

The Pharma Data

OCTOBER 9, 2021

This designation is predicated on data showing that gantenerumab significantly reduced brain amyloid pillar, a pathological hallmark of Notice, in the ongoing SCarlet RoAD and Marguerite RoAD open- tag extension trials, as well as other studies. Roche’s Chief Medical Officer and Head of Global Product Development.

Antibody 52

Antibody In-Vitro Trials Development 52

pharmaphorum

APRIL 20, 2021

NICE’s final appraisal document for Kesimpta will be followed by technology appraisal guidance (TAG) that will pave the way for NHS prescribing in England and Wales. Analyst Philippa Salter of GlobalData recently predicted that Kesimpta’s convenience will make it a sought-after option for RMS patients, driving global sales to $3.3

Sales 108

Sales Medicine Drugs Marketing 108

pharmaphorum

SEPTEMBER 15, 2020

The huge rise in the use of telemedicine services during lockdown has brought care directly to patients in their homes, while pharma’s communications with healthcare professionals (HCPs) has experienced a similar push to digital channels. Jeremy Richter, Tag. We’re all trying to find ways to automate.

Branding 104

Branding Marketing Pharma Companies Life Science 104

XTalks

APRIL 18, 2024

Conversely, a negative result suggests a low probability of amyloid pathology, guiding healthcare providers in clinical decision-making and potentially ruling out Alzheimer’s disease in symptomatic patients. There are currently no FDA-authorized blood tests for detecting Alzheimer’s disease. “The

Clinical Trials 52

Clinical Trials Clinical Trials In-Vitro Protein 52

pharmaphorum

AUGUST 28, 2020

But the advent of COVID-19 is proving to be something of a coming of age for digital epidemiology, which has been putting data from disparate sources to global use for the last 15 years. At this moment, people recognise that monitoring infectious diseases, in the US or globally, is challenging because data takes time. Digital COVID.

Medicine 63

Medicine Research 63

Drug Discovery World

MAY 22, 2023

But are these price tags a barrier to access? In the case of Hemgenix, the assurance behind the price point is that the drug would reduce long-term healthcare costs as patients would have fewer healthcare incidents and need fewer clotting treatments. million per dose.

Gene Therapy 52

Gene Therapy Gene Drugs Contamination 52

Drug Discovery World

OCTOBER 3, 2022

As we sit on the cusp of the next wave of transformations made possible by quantum computing and rely ever more on external collaborations with the big tech companies how will this affect the current portfolio of global R&D facilities? CBRE’s Global ILS Training Director, Adam Prosho, will discuss The Automated Lab and the Human.

Drugs 52

Drugs Scientist Bioinformatics Medicine 52

Pharmaceutical Technology

JUNE 21, 2023

The high price tag may be hard to defend , but with lifetime treatment costs for haemophilia B reaching as high as $23m for some, the single-dose treatment could prove far more cost-effective. Already a big player in haemophilia treatments, CSL licensed exclusive global rights to Hemgenix from gene therapy developers uniQure back in 2021.

Gene Therapy 246

Gene Therapy Gene Protein Sales 246

pharmaphorum

JUNE 2, 2022

However, Ben Hargreaves finds that the blockbuster success that certain treatments are achieving is beginning to raise questions over whether healthcare systems can afford this in the long-term. of the global population are affected by a rare disease. It is estimated that between 3.5 Raising questions.

Drugs 52

Drugs Sales Marketing Development 52

pharmaphorum

NOVEMBER 16, 2022

While this is of tremendous benefit to patients, it provides a headache to the pharma industry and to healthcare systems. The UK’s NICE, the cost-effectiveness body for the country, immediately ruled that such pricing was beyond what the healthcare system could afford. However, with a price tag of €1.58 At more than $2.1

Gene Therapy 124

Gene Therapy Gene Marketing Development 124

pharmaphorum

MAY 24, 2021

Robb DeFilippis, managing director, life sciences, for end-to-end global creative production and sourcing partner Tag in the Americas agrees. The need to escape pharma’s traditional ways of approaching marketing content is becoming ever-clearer as the impact of 2020’s digital transformation of pharma and healthcare reveals itself.

Marketing 77

Marketing Branding Sales Life Science 77

Rethinking Clinical Trials

FEBRUARY 22, 2023

The new way is more collaborative and global. Digital health is upon us, and we want to make sure that technology works for healthcare and that healthcare should not work for technology. The biggest change is that the patient now has a seat at the table. But for outcomes and others you can do virtually.

Clinical Trials 130

Clinical Trials Clinical Trials Trials Nurses 130

XTalks

DECEMBER 21, 2022

As the world continues to experience the effects and aftermath of the COVID-19 pandemic, lessons learned from the biggest global health crisis in recent times spurred changes and adaptations in the life sciences and healthcare. Here are some of the top life science trends and topics from 2022. Gene Therapy Approvals.

Life Science 52

Life Science Gene Therapy Gene Clinical Trials 52

XTalks

NOVEMBER 24, 2022

CSL Behring is set to market the drug after having secured global commercialization rights from uniQure for $450 million in 2020. The Hemgenix approval was granted to CSL Behring , a rare disease biotech company based in Pennsylvania, which developed Hemgenix jointly with gene therapy biotech uniQure.

Gene Therapy 52

Gene Therapy Gene FDA Approval Genetics 52

pharmaphorum

JUNE 15, 2021

The pandemic’s disruption galvanised the biopharma industry into unprecedented action, demonstrating what’s possible when the global scientific community collaborates in exceptional ways and public-private partnerships drive innovation to address a common need. He is a member of Accenture’s Global Management Committee.

Clinical Trials 89

Clinical Trials Clinical Trials Development Marketing 89

XTalks

MARCH 22, 2023

While the company maintains that Hemgenix will ultimately offer a cost savings to the US healthcare system by eliminating the need for these patients to receive weekly injections of factor IX, this case has added renewed vigor to the conversation around drug pricing.

Life Science 97

Life Science Drugs FDA Approval Vaccination 97

Drug Discovery World

NOVEMBER 9, 2023

Novel platforms This session will begin with chariperson’s remarks from Lars Linden, PhD, Vice President, Head, Biologics Research, Bayer HealthCare, which will be followed by a keynote presentation by Agnieszka Kielczewska, PhD, Director, Research, Antibody Discovery and Screening, Biologics Discovery, Amgen. Filip Borgions, Ph.D,

Engineer 52

Engineer Antibody Protein In-Vivo 52

Cloudbyz

JUNE 1, 2023

Multi-Language & Multi-Currency Salesforce offers robust multi-language and multi-currency features, designed to support global businesses operating in different countries, dealing with various languages and currencies. Global Data Centers Salesforce operates a network of global data centers to support its cloud services.

Compliance 79

Compliance Development Branding Production 79

Drug Discovery World

NOVEMBER 13, 2023

Immunocytokines Following chairperson’s remarks from Stefan Zielonka, PhD, Global Head of Antibody Discovery and Protein Engineering, Merck Healthcare KGaA; Professor of Biomolecular Immunotherapy, Technical University of Darmstadt, there will be a keynote presentation from Roberto De Luca, PhD, Head, Therapeutic Antibodies, Philochem.

Protein 59

Protein Antibody Engineer Scientist 59

The Pharma Data

MAY 4, 2021

Frank D’Amelio, Chief Financial Officer and Executive Vice President, Global Supply, stated: “I am very happy with the performance of all of our therapeutic areas this quarter. billion in global revenues; Eliquis globally, up 25% operationally, led by growth in the U.S., percentage points of operational growth.

Vaccination 40

Vaccination Vaccine Production Sales 40

Pharmaceutical Technology

MARCH 17, 2023

These agreements have been particularly propelled by the recent rise in inflationary pressures and pharmaceutical market instability, pushing healthcare systems to find new ways to reduce risks associated with new drugs. In some cases, she said, “[drug] innovation would have been otherwise hindered by their price tag alone”.

Marketing 257

Marketing Drugs Research Analyst Manufacturing 257

Pharmaceutical Technology

NOVEMBER 30, 2022

High rates of obesity place a major burden on healthcare systems as the condition is associated with many major health complications like type 2 diabetes, hypertension, non-alcoholic fatty liver disease, and other bodily dysfunctions. In the US, obesity care is estimated at to cost $147 billion in healthcare spending annually.

Drugs 264

Drugs Manufacturing Hormones Contract Manufacturing 264

Pharmaceutical Technology

NOVEMBER 30, 2022

High rates of obesity place a major burden on healthcare systems as the condition is associated with many major health complications like type 2 diabetes, hypertension, non-alcoholic fatty liver disease, and other bodily dysfunctions. In the US, obesity care is estimated at to cost $147 billion in healthcare spending annually.

Drugs 246

Drugs Manufacturing Hormones Contract Manufacturing 246